This is a terrific early result. We are well on the way to commercial sustainability. I think the CEO's confidence in FDA approval across multiple indication is evident in his recent interviews where he has begun throwing out hints about deciding where additional manufacturing capacity might be based. It's seemingly about getting the best deal on government assistance on that ... not something you'd be pushing publicly if you had significant doubts on approval IMO.
- Forums
- ASX - By Stock
- MSB
- Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-95
-
-
- There are more pages in this discussion • 753 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.01 |
Change
0.003(0.25%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.0¢ | $8.255M | 8.472M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 41700 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 182773 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 265324 | 1.000 |
13 | 92605 | 0.995 |
10 | 96123 | 0.990 |
8 | 218669 | 0.985 |
17 | 160823 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 62536 | 10 |
1.010 | 195067 | 16 |
1.015 | 81532 | 8 |
1.020 | 262166 | 11 |
1.025 | 96113 | 4 |
Last trade - 13.43pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online